The sympathetic skin response (SSR) is a change in skin potential following arousal stimulation, ®rst described by Tarchanoff (1890). SSR is a polysynaptic re¯ex that is activated by a variety of afferent inputs. The ®nal efferent pathway involves pre-and postganglionic sympathetic sudomotor ®bers and ultimately activation of sweat glands by the sympathetic out¯ow. The re¯ex is coordinated in the posterior hypothalamus, upper brain-stem reticular formation and spinal cord. Thus, central or peripheral lesions of the sudomotor system can impair the SSR. The morphology of the SSR is variable and the potentials may be either mono-, bi-, or triphasic. The SSR has been advocated as simple means of assessing sympathetic sudomotor out¯ow in central and peripheral nervous system disorders. However, the correlation of an abnormal SSR with more generalized abnormalities of sympathetic sudomotor dysfunction, autonomic dysfunction or small ®ber sensory neuropathy is often poor.
General description of the method
The sympathetic skin response (SSR) is a change in skin potential following arousal stimulation, ®rst described by Tarchanoff (1890) . SSR is a polysynaptic re¯ex that is activated by a variety of afferent inputs. The ®nal efferent pathway involves pre-and postganglionic sympathetic sudomotor ®bers and ultimately activation of sweat glands by the sympathetic out¯ow. The re¯ex is coordinated in the posterior hypothalamus, upper brain-stem reticular formation and spinal cord. Thus, central or peripheral lesions of the sudomotor system can impair the SSR. The morphology of the SSR is variable and the potentials may be either mono-, bi-, or triphasic. The SSR has been advocated as simple means of assessing sympathetic sudomotor out¯ow in central and peripheral nervous system disorders. However, the correlation of an abnormal SSR with more generalized abnormalities of sympathetic sudomotor dysfunction, autonomic dysfunction or small ®ber sensory neuropathy is often poor.
Physiological background
SSR is generated in deep layers of the skin by re¯ex activation of sweat glands via cholinergic sudomotor sympathetic efferent ®bers. The ultimate morphology of the SSR is determined by the interaction between the sweat glands and surrounding epidermal tissue. Because the SSR is a multisynaptic re¯ex, its latency, amplitude, waveform and tendency to habituation is variable. Although the central organization of the SSR is not completely understood, it is likely to be in¯uenced by input from basal ganglia, the premotor cortex, temporal and frontal cortex as well as by the hypothalamus, limbic system and the reticular formation.
The efferent portion of the re¯ex arc involves ®bers that originate from the hypothalamus and descend uncrossed along the lateral column of the spinal cord to form a small bundle between the pyramidal tract and the anterior-lateral tract. This tract terminates on sympathetic preganglionic neurons in the intermediolateral cell column. Sympathetic nerve ®bers for the upper extremity leave the spinal cord at D5±7 segments, that for the lower extremity at D10±L2. These ®bers project to sympathetic ganglia where the peripheral sympathetic sudomotor ®bers originate (C-®ber). Thus sympathectomy causes abolition of ipsilateral SSR.
Technical requirements
At normal ambient temperatures, synchronized spontaneous¯uctuations in skin potential due to sweat gland activation are recorded from the palms and soles. These potentials are increased during psychological stress and may contaminate the evoked SSR. Thus the situation during recording has to be relaxed, without acoustic disturbances or time pressure. The light should be dimmed. Room temperature should be comfortable and the skin surface temperature 328C.
Recording
Recording is done from glabrous skin and is referenced against hairy skin whose sweat glands are not typically active at normal ambient temperatures. The surface Ag-AgCl electrodes are placed on the palm (active) and referenced against the volar forearm or dorsum of the hand (indifferent); and on the sole of the foot (active) and referenced against the shin or dorsum of the foot (indifferent). The ground electrode is proximal to the recording electrodes. Simultaneous bilateral recording from upper and lower extremities is recommended. The recording time should be 5±10 s, the lower frequency limit 0.1±2 Hz (better ,1 Hz), and the upper limit 100±2000 Hz (not critical). Ampli®ca-tion should be 0.05±3 mV/division.
Stimulation techniques
Electrical stimulation is carried out with a constant current stimulus (0.2 ms, supramaximal, 10±30 mA). Typically the median, posterior tibial, peroneal, sural or supraorbital nerves are stimulated at a strength at least three times the sensory threshold. The stimulus should be strong but tolerable (not noxious). Stimulation has to have an arousal effect, therefore, it is applied at irregular time intervals and at a frequency of approximately 1/min to avoid habituation. If electrical stimulation at one site does not evoke an SSR, other sites of stimulation should be tried. If the response to electrical stimulation is absent the response to acoustic stimuli or to an inspiratory gasp should be tried (Shahani et al. 1984) . Several diligent attempts have to be made to record the potential before deciding that it is absent.
In normal subjects, transcranial magnetic stimu- Electrical stimulation at elbow and popliteal fossa causes only minor latency differences. The click of a magnetic stimulus, coil 40 cm apart from the subject, elicits a reproducible SSR.
lation of the motor strip delivered via a¯at probe positioned over C3 and C4 elicited palmar and plantar SSRs similar both in latency and amplitude to those evoked by median nerve stimulation. The problem with this technique is that the click of the magnetic stimulator could well generate an SSR (see Fig. 1 ).
Normal results
The shape of the SSR is variable. The shortest latency to onset and the maximum peak to trough amplitude of at least 5 recordings is used.
Latency
The latency of the SSR includes afferent conduction (about 20 ms), central processing time (a few milliseconds), and efferent conduction in pre-and slow conducting postganglionic autonomic nerve ®bers. The mean conduction velocity of sudomotor nerve ®bers is about 1±2 m/s. Conduction in postganglionic C ®bers as well as activation time of sweat glands include about 95% of the SSR latency of around 1.5 s at the hands and 2 s at the feet. Therefore, differences in fast afferent conduction are not relevant for the SSR latency and the site of stimulation is also not signi®cant (see Table 1 ). However, the site of recording (palm or sole) is of relevance (see Fig. 1 ). The normal latency is 1.3± 1.5 s when recording from the palm and 1.9±2.1s when recording from the sole.
Amplitude
Measurements in theory should re¯ect the density of spontaneously activatable sweat glands. However, the interaction of the two components, sweat gland and epidermal, makes the absolute amplitude of the evoked EDA dif®cult to interpret. The is also a lack of tight correlation between skin conductance and sudorometric measurements of sweat gland activity (Schondorf 1997) . The amplitude is affected by skin temperature and habituation (Shahani et al. 1984) .
Unfortunately, the reproducibility of the electrically evoked SSR is poor. The within-day variability for 5 consecutive increasing stimuli was 42% for amplitudes in palms and 35% for amplitudes in the soles (Hoeldtke et al. 1992 ). Day-to-day correlation was greater for amplitudes than for latencies (Hoeldtke et al. 1992) . Therefore, several investigators use only lack of SSR as a de®nitely abnormal result.
Although correlation of SSR results after electrical stimulation with gender, age and height was not seen in normal subjects by (Gutrecht 1994) , others have noted that SSR latency increased significantly with age (Hay et al. 1997) . Similarly, an age-dependent decline in SSR amplitude and in fact no SSR could be evoked in the lower extremities of 50% of normal subjects above 60 years (Drory and Korczyn 1993) .
SSR evoked by an auditory stimulus has less inter-and intrasubject latency and waveform variability than the inspiratory gasp induced response. Auditory-evoked SSR latencies reveal a signi®cant non-linear increase with age, while SSR evoked by an inspiratory gasp do not demonstrate age dependence. It is concluded that an auditory stimulus is superior to an inspiratory gasp in evoking SSR. The upper limit of norm for the onset latency at the foot to deep inspiration is 2.2 s and the lower limit for the amplitude is 92 mV.
For normal results see Table 1 .
In¯uencing factors
The in¯uence of age is discussed above. Latency and amplitude are linearly correlated with skin temperature. At low skin temperature, the latency is prolonged and the amplitude decreased.
Source of error: The SSR is absent after sympathectomy or atropine. Furthermore, anticholinergic drugs have a signi®-cant in¯uence on SSR. 
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Diagnostic application
SSR is a poor test of sympathetic sudomotor function. One has to be aware of the fact that SSR speci®cally tests skin sudomotor ®bers that do not participate in thermoregulatory sweating. There is no close correlation between presence or absence of SSR and the severity of autonomic dysfunction. SSR has been used in the diagnosis of polyneuropathy, erectile dysfunction, central degenerative diseases, multiple sclerosis, brain infarction, re¯ex sympathetic dystrophies, spinal and peripheral nerve lesions.
SSR was investigated in 39 patients with polyneuropathy (age 59^18 years), and it was abnormal in 51% in one or both legs. There was neither a correlation of SSR to the etiology nor to the type of lesion (axonal versus demyelinating polyneuropathy) nor to clinical symptoms (Dettmers et al. 1993) . However, SSR is greatly diminished or absent in patients with severe autonomic neuropathies and with orthostatic hypotension.
SSR evoked by peripheral nerve stimulation is absent in at least 50% of patients with obvious diabetic neuropathy. However, SSR evoked by deep inspiration was absent in only 3 of 68 diabetic patients, 19 of whom had symptomatic autonomic neuropathy. Amplitudes are signi®cantly reduced in diabetic patients. SSR was absent in the foot in 66% of patients with diabetic neuropathy. SSR and QSART may be useful for the assessment of autonomic neuropathy in diabetic patients with cardiac arrhythmia where direct measurement of heart rate variability cannot be carried out (Spitzer et al. 1997) . 94% of diabetic patients with absent SSR and 78% of patients with abnormal QSART (quantitative sudomotor axon re¯ex test) had cardiac autonomic neuropathy. Thus the combined use of these different tests of sudomotor function may enhance the ability to uncover early distal sympathetic failure in diabetic neuropathy.
In Guillain±Barre Â syndrome (GBS), SSR was absent in 9 of 24 patients. SSR abnormalities are common in GBS and may be complementary to bed-side tests for autonomic dysfunction. For a review see Arunodaya and Taly 1995. SSR serves in the early diagnosis of autonomic dysfunction in other polyneuropathies including amyloid polyneuropathy. In re¯ex sympathetic dystrophy, mean amplitude of SSR in the involved limb is greater than the mean amplitude of the uninvolved limb, and onset latency of the SSR in the involved limb is shorter than that of the uninvolved limb. Results are, however, not conclusive. SSR is impaired in chronic idiopathic anhidrosis.
SSR sensitivity is 88% in multiple system atrophy (Shy±Drager syndrome), 66±83% in diabetic polyneuropathy and 67% in uremic neuropathy (Hoeldtke et al. 1992) . In idiopathic autonomic failure syndromes and Parkinson's disease, abnormality in SSR may be a result of intermediolateral column dysfunction.
The SSR can be used to assess the integrity of the spinal sympathetic nervous system. In patients with complete tetraplegia and paraplegics with high thoracic lesions (up to level D3), SSR is absent in hands and feet. In patients with complete paraplegia and thoracic lesions, SSR can be evoked in hands but not in feet. All patients with episodes of autonomic dysre¯exia show abolished SSR in hands and feet. SSR results in myelopathies are reviewed by Arunodaya and Taly (1995) . In brain infarction, SSR amplitudes are signi®-cantly decreased and the latencies prolonged in both hemispherical and brain-stem infarctions.
